The GM AHSN Innovation Funds have been established to support the introduction and adoption of needs-led, evidence-based innovations into our healthcare system within the GM AHSN footprint. This will improve the health of our citizens and also promote economic development and wealth creation through the growth of local businesses and jobs.
The Momentum Fund is specifically designed to provide funding support to help SMEs with innovative products or services accelerate progress to significant milestones. These innovations should be focused on GM AHSN priority areas (see below). It is expected that SME applicants will be collaborating with NHS or social care partners and, potentially, academic or other industry partners. Priority will be given to SMEs in the GMAHSN footprint (see below) including inward investing companies establishing a base in the GM area.
GM AHSN will prioritise support to SMEs operating within Greater Manchester, East Lancashire and East Cheshire with innovative products or services that fit within GM AHSN’s current clinical priority areas that will be detailed in the guidance documents.
All applications must include involvement from an NHS or Social Care organisation from within GM AHSN’s footprint.
Consideration will also be given to companies from outside the GM AHSN footprint wishing to work with GM AHSN member Trusts and CCGs, e.g., for trials/evaluations.
Applicants must apply using the Innovation Nexus portal and SMEs are advised to complete an Innovation Nexus business enquiry (via the same link) prior to applying to the Innovation funds. Applications for the Momentum Fund are will open on June 16th at 12pm and close on 14th July 2017 at 9am. For more information about the Momentum Fund please read our application guidance here and watch the webinar that was held on June 16th and can be viewed here.